.css-1k8gaoi.e28r9p60:before { opacity: 1; background-image: linear-gradient(to bottom, rgba(0, 67, 203, 0.9), rgba(224, 54, 90, 0.7)),url('/static/36742c741eb60b24feafebf5af68f094/1a900/riley_lava.jpg'); }

Intelligent design
of living systems

Platform

Asimov builds tools to program living cells.
Our mammalian cell engineering platform advances the design and manufacture of biologics and gene therapies.

CAD software

Computer-aided design, simulation, and debugging of genetic systems.

Cell lines

GMP host cell lines for improved biologics and viral vector manufacturing.

Genetic parts

Optimized vectors and genetic parts database for custom functionality.

We’re currently partnering with leading biopharma companies and CDMOs.
Contact us to learn more.

Focus Areas

Synthetic biology is ushering in an era where therapeutics can be iteratively engineered rather than discovered. Our platform enables an engineering mindset for next-generation medicines.

Monoclonal antibody
manufacturing

Multifunctional and
difficult-to-express
molecule manufacturing

Design of vector payloads
and capsid-specific
optimization

AAV and lentiviral
manufacturing

Technology

Full-stack bioengineering.

Synthetic Biology

Nature has evolved billions of useful molecular devices in the form of genes, across the tree of life. We source, catalog, refine, and remix these genetic components to build new biological systems.

Computer-Aided Design

Biology is complex, and genetic engineering unlocks an unbounded design space. Computational modeling is critical to move synthetic biology beyond traditional brute force screening.

Multi-omics Measurement

Genome-scale, multi-omics measurement technologies provide deep views into the cell. These techniques permit pathway analysis at the scale of a whole cell, and inspection down at single-nucleotide resolution.

Machine Learning

Machine learning bridges large-scale datasets with mechanistic models of biology. Artificial intelligence can augment human capabilities to design and understand biological complexity.

Asimov Inside

We endeavor to build the genetic programs powering the world's most impactful biotechnologies. One day, entire genomes will be designed from the ground up. Come help us build this future.

Meet Our Team

Ours is a culture of recombination, where diverse expertise and experiences intermix. Our team spans synthetic biology, machine learning, computational biology, and automation.